Clinical Trial Update: IUD and Norethindrone Acetate for Treatment of Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an intrauterine device plus norethindrone acetate for endometriosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Intrauterine device (hormonal)
• Norethindrone acetate (Norethindrone acetate)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Endometriosis | Phase 2 | Status: WITHDRAWN